This webinar features a discussion between some of Selvita’s most experienced scientific team members, on selecting small molecule modalities to address protein targets in drug discovery. The debate highlights areas of experience and recommendations for planning approaches for new projects. Dr. Anna Karawajczyk, Head of Computational Chemistry, moderates a discussion of Dr. Tom Coulter, Integrated Drug Discovery Director, Dr. Przemyslaw Zawadzki, Director of Medicinal Chemistry and Dr. Piotr Graczyk, Scientific Director.
